Table 3.
HMGCR flanking regions (±5 kb) | Contralateral kidney | 72 hours I/R |
---|---|---|
Pol II | ||
−5 kb | 0.29 ± 0.02 | 0.24 ± 0.03 (NS) |
+5 kb | 0.26 ± 0.06 | 0.31 ± 0.05 (NS) |
SREBP-1 | ||
−5 kb | 0.067 ± 0.01 | 0.064 ± 0.006 (NS) |
+5 kb | 0.06 ± 0.01 | 0.052 ± 0.006 (NS) |
SREBP-2 | ||
−5 kb | 0.05 ± 0.005 | 0.049 ± 0.01 (NS) |
+5 kb | 0.052 ± 0.007 | 0.055 ± 0.02 (NS) |
NF-κB | ||
−5 kb | 0.26 ± 0.05 | 0.26 ± 0.05 (NS) |
+5 kb | 0.20 ± 0.01 | 0.18 ± 0.01 (NS) |
c-Fos | ||
−5 kb | 0.12 ± 0.01 | 0.14 ± 0.01 (NS) |
+5 kb | 0.11 ± 0.01 | 0.14 ± 0.01 (NS) |
c-Jun | ||
−5 kb | 0.04 ± 0.005 | 0.04 ± 0.005 (NS) |
+5 kb | 0.03 ± 0.005 | 0.03 ± 0.005 (NS) |
HSP-70 | ||
−5 kb | 0.08 ± 0.01 | 0.09 ± 0.01 (NS) |
+5 kb | 0.03 ± 0.005 | 0.03 ± 0.005 (NS) |
HO-1 | ||
−5 kb | 0.06 ± 0.005 | 0.05 ± 0.005 (NS) |
+5 kb | 0.03 ± 0.05 | 0.03 ± 0.005 (NS) |
H2A.Z | ||
−5 kb | 0.14 ± 0.01 | 0.12 ± 0.01 (NS) |
+5 kb | 0.10 ± 0.01 | 0.11 ± 0.01 (NS) |
H3K4m3 | ||
−5 kb | 6.5 ± 0.4 | 6.5 ± 0.3 (NS) |
+5 kb | 6.0 ± 0.02 | 6.3 ± 0.03 (NS) |
H3K9Ac | ||
−5 kb | 0.08 ± 0.01 | 0.09 ± 0.01 (NS) |
+5 kb | 0.07 ± 0.01 | 0.08 ± 0.01 (NS) |
Values are percent of DNA input. No significant differences were observed between control (contralateral) and postischemic kidney samples.